Keybanc analyst Brett Andress downgrades Thor Industries (NYSE:THO) from Overweight to Sector Weight.
Karyopharma Shares Recently Spiked Higher; Hearing Co. Granted Orphan Drug Status For Its Myelodysplastic Syndrome Treatment
https://twitter.com/algobotnews/status/1483891738460700674